MK

Michael D. Kalos

CO Corixa: 22 patents #14 of 134Top 15%
UP University of Pennsylvania: 18 patents #47 of 2,719Top 2%
EL Eli Lilly: 3 patents #1,020 of 2,858Top 40%
NA Novartis Ag: 2 patents #1,923 of 5,128Top 40%
CP Children'S Hospital Of Philadelphia: 2 patents #76 of 358Top 25%
ZY Zymeworks: 1 patents #41 of 65Top 65%
Overall (All Time): #70,397 of 4,157,543Top 2%
43
Patents All Time

Issued Patents All Time

Showing 25 most recent of 43 patents

Patent #TitleCo-InventorsDate
11512134 Anti-CD137 antibodies Christopher Carl Frye, Helen KOTANIDES, Stephanie Lynn SANDEFUR 2022-11-29
11273219 Toxicity management for anti-tumor activity of CARs Carl H. June, Bruce L. Levine, Stephan Grupp 2022-03-15
11203640 Checkpoint inhibitor bispecific antibodies Yiwen Li, Dale Lincoln Ludwig, Yang Shen, Igor Edmondo Paolo D'Angelo, Gregory D. Plowman 2021-12-21
11028177 Effective targeting of primary human leukemia using anti-CD123 chimeric antigen receptor engineered T cells Jennifer Brogdon, Saar Gill, Carl H. June, Andreas Loew, John Scholler 2021-06-08
10906983 Anti-CD137 antibodies Christopher Carl Frye, Helen KOTANIDES, Stephanie Lynn SANDEFUR 2021-02-02
10603378 Toxicity management for anti-tumor activity of CARs Carl H. June, Bruce L. Levine, Stephan Grupp 2020-03-31
9572836 Methods for assessing the suitability of transduced T cells for administration Carl H. June, Bruce L. Levine 2017-02-21
9573988 Effective targeting of primary human leukemia using anti-CD123 chimeric antigen receptor engineered T cells Jennifer Brogdon, Saar Gill, Carl H. June, Andreas Loew, John Scholler 2017-02-21
9540445 Compositions and methods for treatment of cancer Carl H. June, Bruce L. Levine, David L. Porter, Michael C. Milone 2017-01-10
9518123 Compositions and methods for treatment of cancer Carl H. June, Bruce L. Levine, David L. Porter, Michael C. Milone 2016-12-13
9499629 Use of chimeric antigen receptor-modified T-cells to treat cancer Carl H. June, Bruce L. Levine, David L. Porter, Michael C. Milone 2016-11-22
9481728 Compositions and methods for treatment of cancer Carl H. June, Bruce L. Levine, David L. Porter, Michael C. Milone 2016-11-01
9464140 Compositions and methods for treatment of cancer Carl H. June, Bruce L. Levine, David L. Porter, Michael C. Milone 2016-10-11
9328156 Use of chimeric antigen receptor-modified T cells to treat cancer Carl H. June, Bruce L. Levine, David L. Porter, Michael C. Milone 2016-05-03
9101584 Methods for treatment of cancer Carl H. June, Bruce L. Levine, David L. Porter, Michael C. Milone 2015-08-11
9102760 Compositions for treatment of cancer Carl H. June, Bruce L. Levine, David L. Porter, Michael C. Milone 2015-08-11
9102761 Compositions for treatment of cancer Carl H. June, Bruce L. Levine, David L. Porter, Michael C. Milone 2015-08-11
8975071 Compositions for treatment of cancer Carl H. June, Bruce L. Levine, David L. Porter, Michael C. Milone 2015-03-10
8916381 Methods for treatment of cancer Carl H. June, Bruce L. Levine, David L. Porter, Michael C. Milone 2014-12-23
8911993 Compositions for treatment of cancer Carl H. June, Bruce L. Levine, David L. Porter, Michael C. Milone 2014-12-16
8906682 Methods for treatment of cancer Carl H. June, Bruce L. Levine, David L. Porter, Michael C. Milone 2014-12-09
7939646 Compositions and methods for the therapy and diagnosis of prostate cancer Jiangchun Xu, John Stolk 2011-05-10
7517952 Compositions and methods for the therapy and diagnosis of prostate cancer Jiangchun Xu, Davin C. Dillon, Jennifer Mitcham, Susan Harlocker, Yuqiu Jiang +11 more 2009-04-14
7425607 Compositions comprising a lung tumor antigen Robert A. Henderson, Tongtong Wang, Yoshihiro Watanabe, Paul R. Sleath, Jeffrey C. Johnson +7 more 2008-09-16
7202342 Compositions and methods for the therapy and diagnosis of prostate cancer Jiangchun Xu, Davin C. Dillon, Jennifer Mitcham, Susan Harlocker, Yuqiu Jiang +10 more 2007-04-10